{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:59:14Z","timestamp":1790355554425,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cjca.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T16:00:47Z","timestamp":1406131247000},"page":"1027-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["The Role of Biomarkers in Valvular Heart Disease: Focus on Natriuretic Peptides"],"prefix":"10.1016","volume":"30","author":[{"given":"Jutta","family":"Bergler-Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann","family":"Gy\u00f6ngy\u00f6si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.07.014_bib1","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jacc.2010.02.021","article-title":"Natriuretic peptides in common valvular heart disease","volume":"55","author":"Steadman","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib2","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/eurheartj\/ehs190","article-title":"Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal","volume":"33","author":"Bhattacharyya","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.07.014_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0735-1097(01)01383-3","article-title":"Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction","volume":"38","author":"Stanek","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure","volume":"47","author":"Iwanaga","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2004.09.038","article-title":"Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy","volume":"44","author":"Vanderheyden","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"Kragelund","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.07.014_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/heartjnl-2012-303284","article-title":"Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study","volume":"99","author":"Cimadevilla","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.07.014_bib9","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/01.CIR.0000060533.79248.0C","article-title":"Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis","volume":"107","author":"Gerber","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/eurheartj\/ehi236","article-title":"Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease","volume":"26","author":"Weber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib12","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib13","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.ehj.2004.09.033","article-title":"Predictors of outcome in severe aortic stenosis with normal left ventricular function: role of B-type natriuretic peptide","volume":"25","author":"Lim","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/hrt.2005.085506","article-title":"Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis","volume":"92","author":"Weber","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.07.014_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11886-009-0014-z","article-title":"Natriuretic peptides in the management of aortic stenosis","volume":"11","author":"Bergler-Klein","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cjca.2014.07.014_bib16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.amjcard.2004.11.053","article-title":"Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration","volume":"95","author":"Gerber","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib17","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/CIRCULATIONAHA.106.654210","article-title":"B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study","volume":"115","author":"Bergler-Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCIMAGING.112.980201","article-title":"Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics, and outcome: a substudy of the multicenter TOPAS study","volume":"6","author":"Bartko","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2014.07.014_bib19","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/CIRCULATIONAHA.109.929893","article-title":"Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction","volume":"122","author":"Clavel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.echo.2006.11.020","article-title":"Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides","volume":"20","author":"Poulsen","year":"2007","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2014.07.014_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/icvts\/ivt186","article-title":"B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis","volume":"17","author":"Mannacio","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjca.2014.07.014_bib22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.echo.2011.03.012","article-title":"Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis","volume":"24","author":"Iwahashi","year":"2011","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2014.07.014_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjcard.2008.04.055","article-title":"Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis","volume":"102","author":"Pedrazzini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib24","unstructured":"O'Sullivan CJ, Stortecky S, Heg D, et\u00a0al. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation [epub ahead of print]. EuroIntervention 2014 Jan 17. pii: 20140117a-04."},{"key":"10.1016\/j.cjca.2014.07.014_bib25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ijcard.2012.11.116","article-title":"Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation","volume":"168","author":"L\u00f3pez-Otero","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(14)61747-2","article-title":"The course of NT-ProBNP in real-life patients undergoing transfemoral aortic valve implantation","author":"Scherzer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cjca.2012.04.015","article-title":"Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement","volume":"28","author":"Webb","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib28","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","article-title":"2014 AHA\/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ejechocard\/jeq014","article-title":"Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjca.2014.07.014_bib30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/heartjnl-2011-301128","article-title":"Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation","volume":"98","author":"Magne","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.07.014_bib31","first-page":"55","article-title":"Correlation of N terminal pro B-type natriuretic peptide and speckle tracking derived longitudinal strain in severe asymptomatic aortic stenosis","author":"Bergler-Klein","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib32","first-page":"565","article-title":"B-type natriuretic peptide and tissue Doppler for predicting symptoms on treadmill exercise in apparently asymptomatic aortic stenosis","volume":"18","author":"Rajani","year":"2009","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.cjca.2014.07.014_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/hrt.2009.181644","article-title":"Treadmill exercise in apparently asymptomatic patients with moderate or severe aortic stenosis: relationship between cardiac index and revealed symptoms","volume":"96","author":"Rajani","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.07.014_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCULATIONAHA.108.808857","article-title":"Risk score for predicting outcome in patients with asymptomatic aortic stenosis","volume":"120","author":"Monin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/HCO.0b013e32836245e0","article-title":"Low-flow, low-gradient severe aortic stenosis in patients with normal ejection fraction","volume":"28","author":"Dumesnil","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacc.2011.08.072","article-title":"Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification","volume":"59","author":"Lancellotti","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2011.02.059","article-title":"Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome","volume":"58","author":"Herrmann","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival","volume":"63","author":"Clavel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2007.07.174","article-title":"Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation","volume":"127","author":"Weber","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2011.07.016","article-title":"Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation","volume":"58","author":"Pizarro","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/hrt.2007.126508","article-title":"B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation","volume":"94","author":"Gabriel","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.07.014_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9149(03)00849-X","article-title":"Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation","volume":"92","author":"Gerber","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2013.8643","article-title":"Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets","volume":"310","author":"Suri","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.07.014_bib44","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0735-1097(03)00486-8","article-title":"Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation","volume":"41","author":"Sutton","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib45","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.CIR.0000164269.80908.9D","article-title":"B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome","volume":"111","author":"Detaint","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.014_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0828-282X(07)70758-4","article-title":"Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation","volume":"23","author":"Shimamoto","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.amjcard.2009.04.023","article-title":"Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation","volume":"104","author":"Potocki","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/eurjhf\/hfq189","article-title":"Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation","volume":"13","author":"Klaar","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.07.014_bib49","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jacc.2009.06.013","article-title":"Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation","volume":"54","author":"Pizarro","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/eurjhf\/hfs114","article-title":"Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation","volume":"14","author":"Magne","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.07.014_bib51","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/eurheartj\/eht345","article-title":"Left ventricular contractile reserve in asymptomatic primary mitral regurgitation","volume":"35","author":"Magne","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/eurheartj\/ehm553","article-title":"Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation","volume":"29","author":"Kerr","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib53","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezs513","article-title":"Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results","volume":"43","author":"Hwang","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2014.07.014_bib54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cjca.2012.09.006","article-title":"Change of B-type natriuretic peptide after surgery and its association with rhythm status in patients with chronic severe mitral regurgitation","volume":"29","author":"Hwang","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib55","doi-asserted-by":"crossref","unstructured":"Taramasso M, Maisano F, Latib A, et\u00a0al. Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation [Epub ahead of print]. EuroIntervention 2014 Jan 28. pii: 20130914-04.","DOI":"10.4244\/EIJV10I6A128"},{"key":"10.1016\/j.cjca.2014.07.014_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/eurjhf\/hfs214","article-title":"Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regur- gitation and severe congestive heart failure","volume":"15","author":"Neuss","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.07.014_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10554-006-9174-8","article-title":"The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis","volume":"23","author":"Eryol","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2014.07.014_bib58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.hlc.2011.03.112","article-title":"Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosis","volume":"20","author":"Sharma","year":"2011","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2014.07.014_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4250\/jcu.2010.18.4.139","article-title":"B-type natriuretic peptide in isolated severe tricuspid regurgitation: determinants and impact on outcome","volume":"18","author":"Yoon","year":"2010","journal-title":"J\u00a0Cardiovasc Ultrasound"},{"key":"10.1016\/j.cjca.2014.07.014_bib60","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/eurheartj\/ehs465","article-title":"Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study","volume":"34","author":"Neuhold","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib61","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/eurheartj\/eht016","article-title":"Tricuspid valve regurgitation in patients with heart failure: does it matter?","volume":"34","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.07.014_bib62","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jacc.2013.07.100","article-title":"Hot topics in tetralogy of Fallot","volume":"62","author":"Villafa\u00f1e","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/HCO.0000000000000036","article-title":"Brain natriuretic peptide: a biomarker for all cardiac disease?","volume":"29","author":"Mahadavan","year":"2014","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjcard.2011.02.346","article-title":"Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy","volume":"108","author":"R\u00f8sj\u00f8","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2005.11.008","article-title":"Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure","volume":"113","author":"Bergler-Klein","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib66","first-page":"724","article-title":"Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery","volume":"19","author":"Raffa","year":"2010","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.cjca.2014.07.014_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2012.10.015","article-title":"Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study)","volume":"111","author":"Blackshear","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.014_bib68","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2011.01.052","article-title":"Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion","volume":"91","author":"Steinlechner","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2014.07.014_bib69","first-page":"156","article-title":"Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease","volume":"22","author":"Sainger","year":"2013","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.cjca.2014.07.014_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1440-1681.12206","article-title":"Association of inflammation, myocardial fibrosis, and cardiac remodeling in patients with mild aortic stenosis as assessed by biomarkers and echocardiography","volume":"41","author":"Park","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14004784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14004784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T07:50:38Z","timestamp":1538380238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14004784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0828282X14004784"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.07.014","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Biomarkers in Valvular Heart Disease: Focus on Natriuretic Peptides","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}